Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

55 results about "Mixed-mode chromatography" patented technology

Mixed-mode chromatography (MMC), or multimodal chromatography, refers to chromatographic methods that utilize more than one form of interaction between the stationary phase and analytes in order to achieve their separation. What is distinct from conventional single-mode chromatography is that the secondary interactions in MMC cannot be too weak, and thus they also contribute to the retention of the solutes.

Manufacturing process for the production of polypeptides expressed in insect cell-lines

The present invention provides a manufacturing method for polypeptides that are produced in insect cells using a baculoviral expression system. In one example, the insect cell culture is supplemented with a lipid mixture immediately prior to infection (e.g., one hour prior to infection). The polypeptides are isolated from the insect cell culture using a method that employs anion exchange or mixed-mode chromatography early in the purification process. This process step is useful to remove insect-cell derived endoglycanases and proteases and thus reduces the loss of desired polypeptide due to enzymatic degradation. In another example, mixed-mode chromatography is combined with dye-ligand affinity chromatography in a continuous-flow manner to allow for rapid processing of the insect-cell culture liquid and capture of the polypeptide. In yet another example, a polypeptide is isolated from an insect cell culture liquid using a process that combines hollow fiber filtration, mixed-mode chromatography and dye-ligand affinity in a single unit operation producing a polypeptide solution that is essentially free of endoglycanase and proteolytic activities. In a further example, the isolated polypeptides are glycopeptides having an insect specific glycosylation pattern, which are optionally conjugated to a modifying group, such as a polymer (e.g., PEG) using a glycosyltransferase and a modified nucleotide sugar.
Owner:NOVO NORDISK AS

Use of mixed mode chromatography for the capture and purification of basic antibody products

Use of mixed mode chromatography for purification of an antibody from an antibody mixture, for example) a Pichia pastoris fermentation mixture containing impurities such as host cell proteins and DNA is described Mixed mode chromatography is used instead of protein A chromatography and presents certain advantages over protein A chromatography Furthermore, the integration of such a method into a multi-step procedure with other fractionation methods for purification of antibodies suitable for in vivo applications is provided.
Owner:MERCK SHARP & DOHME CORP

Mixed-Mode Chromatography Membranes

Described are composite materials and methods of using them for mixed-mode chromatography. In certain embodiments, the composite material comprises a support member, comprising a plurality of pores extending through the support member; and a multi-functional cross-linked gel. The multi-functional cross-linked gel possesses at least two of the following functions or characteristics: cationic, anionic, hydrophobic, hydrophilic, thiophilic, hydrogen bond donating, hydrogen bond accepting, pi-pi bond donating, pi-pi bond accepting, or metal chelating. The composite materials may be used in the separation or purification of a biological molecule or biological ion.
Owner:NATRIX SEPARATIONS

Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers

This invention relates to the use of mixed mode chromatography for purification of a protein from a mixture containing other materials, including fragmented or aggregated antibodies, host cell proteins, DNA, endotoxin, and / or virus. This invention further relates to the integration of such a method into a multi-step procedure with other fractionation methods for purification of antibodies or other proteins suitable for in vivo applications.
Owner:BIO RAD LAB INC

Solid phase for mixed-mode chromatographic purification of proteins

Proteins are purified by a mixed-mode chromatography system formed by attaching a ligand with cation exchange and hydrophobic functionalities to a large-pore support matrix, the only linkage between the ligand and the support matrix being a chain having a backbone of no more than three atoms between the hydrophobic group and the support matrix.
Owner:BIO RAD LAB INC

Process for the purification of tnfr:fc fusion protein

The present invention relates to the purification of TNFR:Fc fusion protein. More specifically related to process of purification of TNFR:Fc fusion protein wherein the HCP is reduced. The present invention is directed to the use of mixed-mode chromatography and / or affinity chromatography to produce TNFR:Fc fusion protein which is substantially free of at least one of the protein degrading enzyme present in HCP.
Owner:LUPIN LTD

Correctly folded etanercept in high purity and excellent yield

InactiveUS20140072560A1Maximize stabilityMaximize solubilityPeptide/protein ingredientsAntipyreticPresent methodTreatment use
A mixed mode chromatography method for separating correctly folded from incorrectly folded conformations of a given protein is provided. The method is highly effective in separating correctly folded etanercept from incorrectly folded etanercept and aggregates in commercially attractive yields capable of affording etanercept preparations having very high purity in terms of correctly folded etanercept versus incorrectly folded etanercept. The invention is further directed to protein preparations and formulations comprising correctly folded proteins obtained using the present methods, and methods of treatment using the high purity preparations obtained from the mixed mode method.
Owner:COHERUS BIOSCI

Phenyl boronic acid modified silica gel functional chromatographic filler, preparation method and applications thereof

The invention relates to a preparation method and applications of a phenyl boronic acid modified silica gel functional chromatographic filler, wherein Silica Gel is a silica gel, R1 is a phenyl boronic acid derivative, R2 is vinyl or mercapto, R3 is a co-modified modifying group, n is 0-4, and m is 0-3. The present invention provides the preparation method of the chromatographic filler, wherein vinyl or mercapto silane is bonded on the surface of a silica gel by using a modifying reagent such as a silylating agent to obtain an alkenyl or mercapto silica gel, and then the alkenyl or mercapto silica gel and a phenyl boronic acid derivative having mercapto or alkenyl are subjected to a mercapto-olefin click reaction to obtain the phenyl boronic acid modified silica gel functional chromatographic filler. According to the present invention, the preparation method has characteristics of high yield, good repeatability, mild reaction condition, and the like; and the prepared phenyl boronic acid modified silica gel functional chromatographic filler has characteristics of novel structure, a certain hydrophilicity, a certain hydrophobicity and a certain charge responsiveness, can be used as completely-new mixed mode chromatographic filler and the stationary phase, and can be widely used in the separation of various samples.
Owner:EAST CHINA UNIV OF SCI & TECH

Removal of virucidal agents in mixed mode chromatography

The present invention provides chromatography methods for removing a virucidal agent from a target protein such as an antibody. The method uses a hydrophobic, negatively charged mixed mode support that has high affinity for both the target protein and the virucidal agent. The method provides conditions that favor dissociation of the virucidal agent from the protein, allowing the virucidal agent to bind strongly to the support. The target protein is then eluted from the support under conditions such that the virucidal agent remains bound to the support.
Owner:BIO RAD LAB INC

SCX/HIC (Strong Cation Exchange/Hydrophobic) mixed-mode chromatograph stationary phase and preparation method thereof

The invention discloses a strong cation exchange / hydrophobic mixed-mode chromatograph stationary phase, wherein X is -OCH3 or -OCH2CH3; R is shown in the specification, wherein n is equal to 1-5, or R is shown in the specification, wherein n is equal to 1-6; or R is PEG (Polyethylene Glycol) 200-1000. A preparation method comprises the following steps of: bonding cystine on the activated silica gel surface with hydroxyl groups by a silane coupling agent, then using DTT to open cystine disulfide bonds on the silica gel surface and form sulfydryl silica gel, then using H2O2 to oxidize the sulfydryl groups into sulfonic acid groups and form silica-gel derivatives bonded with the sulfydryl groups, and finally reacting with fatty alcohol (or aromatic alcohol or PEG and the like) to obtain the hydrophobic / strong cation exchange chromatograph stationary phase. The stationary phase can realize effective separation of proteins under the hydrophobic mode and the strong cation exchange mode, and one chromatographic column filled with a double-function separating medium can replace two common strong cation exchange / hydrophobic chromatographic columns to carry out separation and purification on the proteins.
Owner:NORTHWEST UNIV

New method for separating out and purifying high-purity lysozyme from egg white

The invention discloses a new method for separating out and purifying high-purity lysozyme from egg white. The method includes the steps that firstly, the surface of a silica gel matrix is decorated with tryptophan molecules serving as ligand of filler, and novel high performance hydrophobic interaction chromatography (HPHIC) filler regulated and controlled by static groups is synthesized; secondly, a chromatographic column which the HPHIC filler is filled with has the reserved characteristics of mixed mode chromatography, and has high selectivity and load capacity for natural protein separation; thirdly, the filler is applied to separation of an egg white sample, and high-purity and high-activity protein lysozyme with the purity of 99% and the quality recycling rate of 97.8% can be obtained. A salt-water elution system is adopted for the separation and purification process, and the new method is safe, environmentally friendly and beneficial for preparing lysozyme on a widened scale.
Owner:NORTHWEST UNIV

Purification of vwf

The present invention provides a method of purifying multimeric von Willebrand Factor (VWF) from a solution comprising multimeric VWF and contaminants. The method comprises passing the solution through a chromatography column comprising beads of a mixed mode chromatography resin coated with a size-exclusion inactive shell and collecting the multimeric VWF which passes through the column without binding to the resin.
Owner:CSL LTD

Separation and purification method for isomers of anthocyanin compound in lycium ruthenicum murr

The invention provides a separation and purification method for isomers of an anthocyanin compound in lycium ruthenicum murr. Particularly, the method is to efficiently separate and purify the isomers of the anthocyanin compound from a lycium ruthenicum murr extract by adopting mixed-mode chromatography; a mixed-mode chromatographic column is an inverted-phase / strong anionic exchange mixed-mode chromatographic column; efficient separation of the anthocyanin isomers is realized under a low-pH condition by adopting the mixed-mode chromatography; a linear gradient, stepwise gradient or isocratic elution mode is used. A lycium ruthenicum murr ethyl alcohol extract is selected for inversed phase chromatographic preparation and separation to obtain 2 fractions; two pairs of cis-trans anthocyanin isomers, including a new anthocyanin and 3 anthocyanin monomer compounds separated from the lycium ruthenicum murr at the first time, are prepared through the mixed-mode chromatography. The method is excellent in separation effect on the cis-trans anthocyanin isomers, and can realize efficient separation and purification of the anthocyanin isomers and provide a substance basis for research on the activity of an anthocyanin compound.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Purification of Polysaccharide Protein Conjugates

The invention describes a method of purifying polysaccharide protein conjugates using mixed mode chromatography. The method involves contacting a crude polysaccharide protein conjugate with a mixed mode resin comprising an inert porous shell and an activated core under conditions of low conductivity that allow binding of the contaminants and collecting the unbound polysaccharide protein conjugate in a flowthrough.
Owner:SHANTHA BIOTECHNICS

Mixed-mode chromatography stationary phase based on hydrophobic effect and silver ion pi effect and preparation method and use thereof

The invention relates to chromatography stationary phase material and a preparation method and use thereof. Mixed-mode chromatography stationary phase based on hydrophobic effect and silver ion pi effect is characterized in that according to a structural formula, R is methoxyl, ethyoxyl or Cl; the mixed-mode chromatography stationary phase is characterized by simple preparation and good separation effect; the mixed-mode chromatography stationary phase is used for separating triglyceride from grease; separation effect is good; in addition, the mixed-mode chromatography stationary phase has good application prospect.
Owner:INST OF OIL CROPS RES CHINESE ACAD OF AGRI SCI

Separation method of proteins

The invention provides a separation method of proteins. A reversed phase / ion exchange mixed mode chromatography filler adopts a polar copolymerization bonding method and is adopted in the separation process of the separation method, a non-polar group and a polar group are simultaneously bonded on the silica gel surface, a separation mode is reversed phase / electrostatic repulsion interaction, and the separation method uses a reversed phase separation system; the reversed phase / electrostatic repulsion interaction means that 1) a non-polar group on the fixed phase surface provides reversed phasehydrophobic interaction; 2) a pH value of eluent is regulated from acid to neutral, so that a polar group on the fixed phase surface is positively charged; the pH value of the eluent is set to be lessthan an isoelectric point of each of the proteins required to be separated, so that the protein is positively charged; the positively-charged protein and the positively-charged polar group of a fixedphase filler generate electrostatic repulsive interaction, and the various proteins are separated due to different repulsive forces. The separation method provided by the invention has the characteristics of stability, high efficiency and unique selectivity.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Reversed phase/ion exchange mixed mode chromatography stationary phase, preparation method and application

The invention relates to a reversed phase / ion exchange mixed mode chromatography stationary phase, a preparation method and an application. The reversed phase / ion exchange mixed mode chromatography stationary phase is called as an octadecyl / sulfonic acid group mixed chromatography stationary phase, and consists of the octadecyl and the sulfonic acid group bonded to the surface of porous silica gel. The preparation method is as follows: bonding gamma-(2,3-epoxypropoxy)propyltrimethoxysilane KH-560 to the surface of the porous silica gel particle by the chemical vapor deposition method, and respectively carrying out a reaction of KH-560 as a linker arm with sodium bisulfite and octadecyl chloride to prepare the octadecyl / sulfonic acid group mixed chromatography stationary phase.
Owner:TIANJIN UNIV

Purification of multispecific antibodies

The present invention provides methods of purifying multispecific antibodies. The methods comprise the sequential steps of performing a capture chromatography, a first mixed mode chromatography and a second mixed mode chromatography. In some aspects, the invention provides compositions of multispecific antibodies, which compositions have reduced levels of one or more product-specific impurities and / or process-specific impurities.
Owner:GENENTECH INC

Purification of fkpa and uses thereof for producing recombinant polypeptides

The present invention provides methods for producing FKBP-type peptidyl-prolyl cis-trans isomerase (FkpA) polypeptides at very high levels of purity. Also provided we ultrapure FkpA and methods of using same, e.g., for use in immunoassays to show removal of FkpA from biologics produced in bacteria. In addition, the present invention provides methods of purifying polypeptides (e.g., multispecific antibodies) produced in bacteria overexpressing one or more chaperones. The methods include affinity chromatography, mixed-mode chromatography and hydrophobic interaction chromatography. in some aspects, the invention provides compositions of polypeptides (e.g., multispecific antibodies) that are essentially fee of product-specific impurities.
Owner:GENENTECH INC

Optimized method for antibody capturing by mixed mode chromatography

Herein is reported a method for the purification of an antibody directly captured from clarified cell culture supernatants using Streamline CST and / or Capto MMC, wherein especially product related (aggregates and fragments) and process related impurities (host cell protein, media components) could efficiently be removed, resulting in a preparation with a purity comparable to classical protein A affinity chromatography.
Owner:F HOFFMANN LA ROCHE & CO AG

Solid phase for mixed-mode chromatographic purification of proteins

Proteins are purified by a mixed-mode chromatography system formed by attaching a ligand with cation exchange and hydrophobic functionalities to a large-pore support matrix, the only linkage between the ligand and the support matrix being a chain having a backbone of no more than three atoms between the hydrophobic group and the support matrix.
Owner:BIO RAD LAB INC

Method for producing factor H from a plasma precipitation fraction

ActiveUS10183976B2Reduce amidolytic activity and proteolytic clippingSenses disorderPeptide/protein ingredientsIon exchangeBlood plasma
The present disclosure provides, among other aspects, improved methods for the manufacture of Factor H compositions from plasma precipitation fractions. In some aspects, the methods include an improved process step for extracting Factor H from a plasma precipitate fraction with reduced co-extraction of amidolytic activities. In other aspects, the methods include a heat treatment step for reducing impurities, such as amidolytic enzymes, from a Factor H composition. In yet other aspects, the methods include improved anion exchange, heparin affinity, and / or mixed mode chromatographic enrichment of Factor H. In still other aspects, the improved methods include a combination of the individual improved process steps disclosed herein.
Owner:TAKEDA PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products